MGNX – Macrogenics Inc
MacroGenics, Inc.MGNX
$1.78Name : MacroGenics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $112,300,736.00
EPSttm : -0.88
MacroGenics, Inc.
$1.78
22.76%$0.33Float Short %
10.52
Margin Of Safety %
Put/Call OI Ratio
0.87
EPS Next Q Diff
0.3
EPS Last/This Y
-0.75
EPS This/Next Y
-1.04
Price
1.76
Target Price
4.2
Analyst Recom
2.57
Performance Q
-21.59
Relative Volume
2.91
Beta
1.63
Ticker: MGNX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-05-08 | MGNX | 1.535 | 1.10 | 0.00 | 2170 |
| 2025-05-09 | MGNX | 1.425 | 1.10 | 0.00 | 2170 |
| 2025-05-12 | MGNX | 1.59 | 1.08 | 0.00 | 2198 |
| 2025-05-13 | MGNX | 1.56 | 1.07 | 0.95 | 2211 |
| 2025-05-14 | MGNX | 1.555 | 1.06 | 0.40 | 2242 |
| 2025-05-15 | MGNX | 1.54 | 1.04 | 1.25 | 2281 |
| 2025-05-16 | MGNX | 1.58 | 1.03 | 0.00 | 2286 |
| 2025-05-19 | MGNX | 1.59 | 0.92 | 0.00 | 2085 |
| 2025-05-20 | MGNX | 1.56 | 0.91 | 1.50 | 2097 |
| 2025-05-21 | MGNX | 1.485 | 0.91 | 1.50 | 2097 |
| 2025-05-22 | MGNX | 1.575 | 0.90 | 0.00 | 2095 |
| 2025-05-23 | MGNX | 1.51 | 0.90 | 0.00 | 2100 |
| 2025-05-27 | MGNX | 1.48 | 0.88 | 0.22 | 2115 |
| 2025-05-28 | MGNX | 1.39 | 0.88 | 0.22 | 2115 |
| 2025-05-29 | MGNX | 1.395 | 0.88 | 0.22 | 2115 |
| 2025-05-30 | MGNX | 1.36 | 0.88 | 0.00 | 2118 |
| 2025-06-02 | MGNX | 1.39 | 0.88 | 0.00 | 2124 |
| 2025-06-03 | MGNX | 1.515 | 0.88 | 0.00 | 2125 |
| 2025-06-04 | MGNX | 1.495 | 0.87 | 0.00 | 2126 |
| 2025-06-05 | MGNX | 1.445 | 0.86 | 999.99 | 2146 |
| 2025-06-06 | MGNX | 1.765 | 0.87 | 0.00 | 2156 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-05-08 | MGNX | 1.53 | 17.9 | - | -2.89 |
| 2025-05-09 | MGNX | 1.43 | 17.9 | - | -2.89 |
| 2025-05-12 | MGNX | 1.59 | 17.9 | - | -2.89 |
| 2025-05-13 | MGNX | 1.54 | 17.9 | - | -2.89 |
| 2025-05-14 | MGNX | 1.55 | 17.9 | - | -2.89 |
| 2025-05-15 | MGNX | 1.54 | 17.9 | - | -2.89 |
| 2025-05-16 | MGNX | 1.59 | 17.9 | - | -2.89 |
| 2025-05-19 | MGNX | 1.59 | 15.7 | - | -2.15 |
| 2025-05-20 | MGNX | 1.57 | 15.4 | - | -2.15 |
| 2025-05-21 | MGNX | 1.47 | 15.4 | - | -2.15 |
| 2025-05-22 | MGNX | 1.58 | 15.4 | - | -2.15 |
| 2025-05-23 | MGNX | 1.51 | 15.4 | - | -2.15 |
| 2025-05-27 | MGNX | 1.49 | 15.4 | - | -2.15 |
| 2025-05-28 | MGNX | 1.39 | 15.4 | - | -2.15 |
| 2025-05-29 | MGNX | 1.40 | 15.4 | - | -2.15 |
| 2025-05-30 | MGNX | 1.36 | 15.4 | - | -2.15 |
| 2025-06-02 | MGNX | 1.39 | 25.8 | - | -1.82 |
| 2025-06-03 | MGNX | 1.51 | 25.8 | - | -1.82 |
| 2025-06-04 | MGNX | 1.50 | 25.8 | - | -1.82 |
| 2025-06-05 | MGNX | 1.45 | 25.8 | - | -1.82 |
| 2025-06-06 | MGNX | 1.76 | 25.8 | - | -1.82 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-05-08 | MGNX | -0.01 | -0.95 | 9.20 |
| 2025-05-09 | MGNX | -0.01 | -0.95 | 9.20 |
| 2025-05-12 | MGNX | -0.01 | -0.22 | 9.79 |
| 2025-05-13 | MGNX | -0.01 | -0.22 | 9.79 |
| 2025-05-14 | MGNX | -0.01 | -0.22 | 9.79 |
| 2025-05-15 | MGNX | -0.01 | -0.22 | 9.82 |
| 2025-05-16 | MGNX | -0.01 | -0.22 | 9.82 |
| 2025-05-19 | MGNX | -0.01 | 0.36 | 9.79 |
| 2025-05-20 | MGNX | -0.01 | 0.36 | 9.79 |
| 2025-05-21 | MGNX | -0.01 | 0.36 | 9.79 |
| 2025-05-22 | MGNX | -0.01 | 0.36 | 9.79 |
| 2025-05-23 | MGNX | -0.01 | 0.36 | 9.79 |
| 2025-05-27 | MGNX | -0.01 | -7.58 | 9.80 |
| 2025-05-28 | MGNX | -0.01 | -7.58 | 10.52 |
| 2025-05-29 | MGNX | -0.01 | -7.58 | 10.52 |
| 2025-05-30 | MGNX | -0.01 | -7.58 | 10.52 |
| 2025-06-02 | MGNX | -0.01 | -5.12 | 10.52 |
| 2025-06-03 | MGNX | -0.01 | -5.12 | 10.52 |
| 2025-06-04 | MGNX | -0.01 | -5.12 | 10.52 |
| 2025-06-05 | MGNX | -0.01 | -5.12 | 10.52 |
| 2025-06-06 | MGNX | -0.01 | -5.12 | 10.52 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.65
Avg. EPS Est. Current Quarter
-0.66
Avg. EPS Est. Next Quarter
-0.35
Insider Transactions
-0.01
Institutional Transactions
-5.12
Beta
1.63
Average Sales Estimate Current Quarter
16
Average Sales Estimate Next Quarter
23
Fair Value
Quality Score
40
Growth Score
50
Sentiment Score
23
Actual DrawDown %
95.2
Max Drawdown 5-Year %
-97
Target Price
4.2
P/E
Forward P/E
PEG
P/S
0.73
P/B
1.42
P/Free Cash Flow
EPS
-0.89
Average EPS Est. Cur. Y
-1.82
EPS Next Y. (Est.)
-2.86
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-36.23
Relative Volume
2.91
Return on Equity vs Sector %
-94.6
Return on Equity vs Industry %
-76.6
EPS 1 7Days Diff
0.3
EPS 1 30Days Diff
1.07
EBIT Estimation
MacroGenics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 341
MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule for the treatment of solid tumors, which is in preclinical trials. It is also developing next generation T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.
stock quote shares MGNX – Macrogenics Inc Stock Price stock today
news today MGNX – Macrogenics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MGNX – Macrogenics Inc yahoo finance google finance
stock history MGNX – Macrogenics Inc invest stock market
stock prices MGNX premarket after hours
ticker MGNX fair value insiders trading